Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancer

Autoantibodies against tumor antigens represent one type of biomarker that may be assayed in serum for detection of cancer and monitoring of disease progression. In the present study, we used a proteomics‐based approach to identify novel tumor antigens in non‐small cell lung cancer (NSCLC). By combi...

Ausführliche Beschreibung